Secondary Logo

Journal Logo

Depression and the Risk of Myocardial Infarction and Coronary Death

A Meta-Analysis of Prospective Cohort Studies

Wu, Qing MD, ScD; Kling, Juliana M. MD, MPH

Section Editor(s): Xie., Wuxiang

doi: 10.1097/MD.0000000000002815
Research Article: Meta-Analysis of Observ Studies in Epidemiology

Findings regarding the association between depression and risk of coronary heart disease are inconsistent. We aimed to assess the association between depression and risk of myocardial infarction (MI) and coronary death through a meta-analysis.

We performed an electronic literature search of MEDLINE, EMBASE, PsycINFO, ISI Web of Science, and Scopus databases through August 1, 2015, and manual search of the references of the eligible papers and related review articles. Two investigators independently conducted study selection and data abstraction. Disagreement was resolved by consensus. Confounder-adjusted hazard ratios (HRs) were pooled using a random-effects model. Heterogeneity was evaluated using the Cochran Q statistic and Higgins index. Publication bias was assessed by funnel plot and Egger test. Study quality was appraised with the Newcastle-Ottawa Scale.

Among 19 eligible cohort studies including 323,709 participants, 8447 cases of MI and coronary death were reported during follow-up ranging from 4 to 37 years. The pooled adjusted HRs for patients with depression (vs those without) were 1.22 (95% CI, 1.13–1.32) for combined MI and coronary death, 1.31 (95% CI, 1.09–1.57) for MI alone (9 studies), and 1.36 (95% CI, 1.14–1.63) for coronary death alone (8 studies). The increased risk of MI and coronary death associated with depression was consistent using modified inclusion criteria, across most subgroups, and after adjusting for possible publication bias.

Depression is associated with a significantly increased risk of MI and coronary death. Effective prevention and treatment of depression may decrease such risk.

From the Nevada Institute of Personalized Medicine (QW), and Department of Environmental and Occupational Health, School of Community Health Sciences (QW), University of Nevada Las Vegas, Las Vegas, NV, and Division of Women's Health Internal Medicine (JMK), Mayo Clinic, Scottsdale, AZ.

Correspondence: Qing Wu, Nevada Institute of Personalized Medicine, University of Nevada Las Vegas, 4505 Maryland Parkway, Las Vegas, NV 89154-4009 (e-mail:

Abbreviations: CHD = coronary heart disease, HR = hazard ratio, MI = myocardial infarction, REDCap = Research Electronic Data Capture, RR = relative risk.

Presented at the 2014 Joint Statistical Meeting, Boston, MA; August 6, 2014.

All authors had access to the data and a role in writing the manuscript.

The project was supported by Mayo Clinic Center for Translational Science Activities grant support (UL1 RR024150; REDCap project), Mayo Clinic Research, and knowledge fund of University of Nevada, Las Vegas from Nevada Governor's Office.

None of the funding sponsors were involved in the study design, data collection, management, analysis, and interpretation of the data; and preparation, review and or approval of this manuscript.

The authors have no conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (

This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Received November 24, 2015

Received in revised form January 14, 2016

Accepted January 17, 2016

Back to Top | Article Outline


Coronary heart disease (CHD) remains the leading cause of death in the United States, United Kingdom, and other Western countries, although its mortality rates have decreased slightly because of advances in health care. In 2010, an estimated 379,559 deaths in the United States were caused by CHD, ≈1 in every 6 deaths.1 In the United Kingdom, this number is more than 65,000, which is more than deaths from any other disease.2 In many developing countries, mortality and morbidity from CHD have increased exponentially. In 2008, an estimated 7.3 million global deaths resulted from CHD;3 thus, it is becoming the leading cause of death worldwide.

Another common disorder, depression, affects 26% of women and 18% of men in the United States.4 Many studies have examined the effects of depression on the risk of CHD, especially as a potential modifier of myocardial infarction (MI) and coronary death. Results from previous meta-analyses and reviews, however, have been inconsistent.5–10 These meta-analyses included either studies with other than a prospective design or a different subset of available studies, or studies with heterogeneous outcomes of heart diseases. None have offered a comprehensive review of all the relevant evidence in prospective cohort studies to investigate the association between depression and the risk of MI or death due to CHD.

The aims of this meta-analysis were to quantitatively assess all qualified prospective cohort studies that have examined the effect of depression on the risk of MI or death due to coronary diseases and to gather more accurate and precise information about this effect.

Back to Top | Article Outline


This meta-analysis followed the MOOSE guidelines,11 with reference to the PRISMA statement,12 regarding the literature search, inclusion criteria, study selection, data abstraction, study appraisal, and data analysis. Articles in other languages were reviewed and evaluated by multilingual investigators; the same criteria and assessment methods were employed. Institutional review board approval was not required because this meta-analysis only used published data and no patient consent was needed. We preregistered our protocol on PROSPERO (CRD42015026892) and is available at:

Back to Top | Article Outline

Eligibility Criteria

Because of the bidirectional relationship between depression and CHD, this meta-analysis only included original prospective cohort studies that evaluated the effects of depression on the risk of MI or CHD death, in which depression is the predictor and MI and CHD death is the outcome. Case–control and cross-sectional studies were excluded.

Eligible exposures were unipolar depression assessed by clinical diagnosis or depressive mood measured by a standardized psychometric tool. In this meta-analysis, the term “depression” refers to clinical depression, depressive disorder, and depressive mood. Bipolar depression and bipolar depressive disorder were excluded.13 Eligible outcomes were fatal or nonfatal MI or death due to CHD. We excluded angina pectoris because some studies have demonstrated that some patients with depression report chest pain but have normal coronary arteries.14,15

Included studies were required to have a control group (no depression) and to report adjusted hazard ratio (HR) or relative risk (RR) of outcomes between depressed and nondepressed participants. Studies that analyzed depression as a continuous variable and did not report HR or RR between a depressed and nondepressed group were excluded.

Back to Top | Article Outline

Literature Search

A literature search of MEDLINE was conducted, using both Ovid and PubMed from January 1966 through August 2015, without language restrictions. Two major search themes were combined using the “and” Boolean operator. The first theme, depression, combined the exploded versions of the Medical Subject Headings “depression” and “depressive disorder.” The second theme, MI and coronary death, combined exploded versions of the Medical Subject Heading terms “coronary disease” and “myocardial infarction.” The key word “coronary heart disease(s)” was also used in the search. The same search strategy was used with the databases EMBASE (from 1988), PsycINFO (from 1806), ISI Web of Science (from 1975), and Scopus (from 1960), with the last search performed on August 1, 2015. Ovid AutoAlert automatically updated the MEDLINE literature search to November 3, 2015. We then manually searched the reference lists of eligible papers and related review articles retrieved in the electronic search. We searched abstracts listed in WorldCat Dissertations and Theses using the key words “depressive disorder,” “depression,” and “heart disease(s).” An experienced medical librarian was consulted for the literature search. We also used Google to search for conference materials, abstracts, and unpublished data. The 2 investigators independently examined reference lists manually from included original studies16–34 and review articles.5–9,35,36

Back to Top | Article Outline

Study Selection

All references from electronic database searches, including abstracts, were merged and stored in Endnote (Thomson Reuters), Philadelphia, PA, USA; duplicates were removed by experienced librarians. The 2 investigators independently screened the title and abstract of each reference in the EndNote database to identify potentially eligible studies and then independently reviewed the full contents to determine their eligibility for this meta-analysis. Agreement between investigators was assessed with the κ statistic. Disagreement regarding eligibility was resolved by consensus.

Back to Top | Article Outline

Study Appraisal

We used the Newcastle-Ottawa Scale37 to assess the methodological quality of included studies (eTable 1, These items were prespecified in the Research Electronic Data Capture (REDCap) tool hosted at Mayo Clinic.38 REDCap is a secure, web-based application designed to support data capture for research studies. As recommended by the MOOSE study group,11 the quality scores were not used as weights in the analyses but as differentiators in the subgroup analysis (score <7 vs ≥7).

Back to Top | Article Outline

Data Abstraction

All data were independently abstracted by the 2 investigators using the REDCap tool.38 Disagreement or uncertainty was resolved by discussion. The following information was recorded: authors, title, year published, and study country; study design, sample size, and sampling methods; distribution by age, sex, and race; exposures and their measurement methods; outcomes and their validation methods; duration of follow-up; adjusted risk factors; and HR or RR of MI or CHD death associated with depression. If the original study gave multiple estimates of the same outcome from the nested regression models, we used the estimate adjusting for the most confounders. We did not contact authors because no further information was needed for eligible studies.

Back to Top | Article Outline

Statistical Analysis

HR was used as a measure of the association between depression and the risk of MI or CHD death. RR was considered equivalent to HR. The confounder-adjusted HR or RR was the primary outcome. The HRs or RRs of individual studies were transformed to natural logarithms to stabilize the variance and normalize the distributions.39 For the overall pooled analysis, the longest duration of follow-up was used in cases of multiple data points over time. To pool overall effect size, each study was weighted by the reciprocal of its variance. Outcome heterogeneity across studies was assessed with the Cochran Q statistic (P < 0.1 indicated statistically significant heterogeneity)40 and Higgins index (I2) (values of 75%, 50%, and 25% indicated high, medium, and low heterogeneity, respectively).41 Due to heterogeneity among studies, all pooled analyses used random-effects models.

Multiple sensitivity analyses were conducted to evaluate the findings of the meta-analysis using different assumptions. We conducted several subgroup analyses based on the quality of study methods, sex, mean age of participants at baseline, sample size, duration of follow-up and others. A cumulative meta-analysis was conducted by undertaking sequential random-effects pooling, starting with the earliest, eligible study. Each successive meta-analysis then summarized all included studies in the preceding years. Results were presented chronologically in a forest plot to demonstrate the impact of adding studies on the pooled estimate. No multivariate meta-regression analysis was performed because no significant difference was found between groups in the subgroup analysis.

To examine for possible publication bias, we used funnel plots and the Egger test.42 Furthermore, the Duval and Tweedie nonparametric trim-and-fill method43 was used to assess and adjust for the potential effects of unpublished studies on the pooled estimate.

The absolute risk differences associated with depression were calculated by multiplying the background incidence rate of MI and CHD death in the general US population by estimated HR – 1. We calculated population-attributable risk as: Pe(HRe – 1)/[1 + Pe(HRe – 1)]; where Pe is the prevalence of depression and HRe was calculated from the present meta-analysis. All data analyses were performed with Stata 10.0 software (STATA Corp, College Station, TX, USA).

Back to Top | Article Outline


Literature Search and Study Selection

The study flow diagram is shown in Figure 1. After eliminating duplicate publications, we identified 22,067 potential articles. Initial screening of titles and abstracts resulted in 203 full-text articles assessed for eligibility, with modest agreement between the 2 investigators (κ = 0.66). After full review of these articles, 19 studies (all published in English) met the inclusion criteria,16–34 with good agreement between the investigators (κ = 0.92).



Back to Top | Article Outline

Study Characteristics

The characteristics of the study participants and the designs of the cohort are summarized in Table 1 and eTable 2, Among the cohort studies, 11 were conducted in the United States, 8 included only women, and 8 included only patients aged 65 years and older. The number of participants ranged from 1190 (18) to 63,469 (28), and the number of cases of MI and coronary death ranged from 20 (19) to 2111 (33). The mean follow-up period ranged from 4 (22) to 37 (29) years.



Back to Top | Article Outline

Overall Analysis

Data were analyzed for a total of 323,709 persons, a majority of whom were women (58.1%); 8447 cases of MI and CHD death were reported during follow-up. The Cochran Q statistic (P < 0.001) and the Higgins I2 index (78.5%) indicated that there was heterogeneity among the 19 studies. Figure 2 shows the HR of MI and death due to CHD associated with depression in each study and overall. Compared with nondepressed persons, depressed people had an overall HR of 1.22 (95% CI, 1.13–1.32; P < 0.001). Of the 19 eligible studies, 9 used MI as an outcome and 8 used coronary death as an outcome. Overall, depression was associated with a 31% increase in the risk of MI (HR, 1.31; 95% CI, 1.09–1.57; P < 0.001) (eFigure 1,; depression was associated with a 36% increase in the risk of coronary death (RR, 1.36; 95% CI, 1.14–1.63; P < 0.001) (eFigure 2,



On the basis of 2015 heart disease statistics,44 the absolute risk difference associated with depression in the United States was estimated to be 51 cases of MI and 40 coronary deaths per 100,000 persons per year. According to the most recent data from the National Institute of Mental Health, an estimated 16 million adults in the United States (6.9%) meet the definition for current depression.45 Using the risk estimates from the present meta-analysis, we estimate that 2.4% of coronary deaths (n = 9000) and 2.1% of MI cases (n = 13,300) in the United States could be attributable to depression.

Back to Top | Article Outline

Sensitivity Analysis and Subgroup Analysis

Table 2 summarizes results of sensitivity analysis; the pooled estimated HR changed little when studies with different inclusion criteria were excluded. The cumulative meta-analysis demonstrated that the evidence was consistent since 1998 (eFigure 3, The pooled HR estimates and their CIs stabilized from 2013 and remained unchanged, even after adding 2 large studies.33,34 This result suggests that the addition of a future study, even if it included thousands of participants, would add little to the cumulative body of evidence. Table 3 summarizes the pooled estimates of HR associated with depression in subgroups of studies according to mean age at baseline, sex, study methodology quality, sample size, controlling key confounders, publication year, and geographic location. Depression significantly increased the risk of MI and CHD death in all subgroups except in women (P = 0.08) and studies that had mean follow up less than eight years (P = 0.27). The increased risk was more evident in several subgroups (Table 3), but no significant between-group differences were observed. Moderate to high heterogeneities were observed in most of these analyses.





Back to Top | Article Outline

Analysis of Publication Bias

Publication bias was suspected in this meta-analysis, as indicated by the funnel plot (Figure 3), which revealed asymmetry. The Egger test was significant (t = 5.95; P < 0.01). We conducted a sensitivity analysis by using the trim-and-fill method; a symmetrical funnel plot was produced with 6 imputed studies. The overall estimate was smaller after trim-and-fill correction, but it remained statistically significant (HR, 1.17; 95% CI, 1.08–1.27; P < 0.001).



Back to Top | Article Outline


Our meta-analysis showed that depression is prospectively associated with a significant increase in the risk of MI and coronary death. Furthermore, the increased risk associated with depression persisted and remained statistically significant in sensitivity analyses on the basis of various inclusion criteria and in all subgroup analyses stratified by various participant and study characteristics. In addition, the cumulative meta-analysis also demonstrated that our results are robust and consistent. A positive association was found when pooled analysis was performed for MI and coronary death separately. Although the risk associated with depression found in this meta-analysis was moderate, because of the high prevalence of depression, the estimated absolute risk differences associated with depression were substantial, with 13,300 cases for MI and 9000 cases for coronary death in the United States alone. Given that depression is prevalent worldwide, the findings of our meta-analysis have important implications for global public health.

The results of our meta-analysis are consistent with those of 2 previous meta-analyses that assessed the confounder-adjusted effect of depression on fatal CHD and incident MI. The first, by Rugulies,5 included 11 studies published before 1999, and the overall RR was 1.64 (95% CI, 1.29–2.08). The second, by Nicholson et al,8 presented an overall confounder-adjusted effect from 12 studies published before 2004, the estimate of overall RR was 1.90 (95% CI, 1.49–2.42). Although both meta-analyses presented larger overall estimates than our study, their results were restricted because these meta-analyses included crude RR or age-adjusted RR, and these unadjusted confounders tend to exaggerate the estimate. Due to incomplete and biased availability of adjustments for coronary risk factors, Nicholson et al suggested additional evaluation is warranted to establish the association between depression and CHD risk. Our meta-analysis attempted to minimize this problem by only including studies which adjusted for most of the important confounders. In addition, both previous meta-analyses had a substantially smaller sample size than our study. Our meta-analysis, with 7 times more cases, provides strong evidence that depression is associated with an increased risk of MI and coronary death. Finally our cumulative meta-analysis also demonstrated that our pooled estimate stabilized in 2013 and remained unchanged after 2 new studies were added,18,19 which suggests that even adding a future large study would have little impact on our estimate. Other earlier meta-analyses and reviews focused on different outcomes, either incidence of other CHD events6,7 or broad cardiovascular disease outcomes.9 A more recent meta-analysis by Gan et al,10 which combined studies with 2 different outcomes—development of various CHDs and death due to CHD—was restricted because it had omitted several major eligible studies21,23,25,27 but included duplicate reports from the same NHANES I study population46,47 and included ineligible studies with RR from continuous depression scores.48,49 By contrast, our meta-analysis focused on MI and coronary death only, excluded angina pectoris and other nondefinitive CHD outcomes, and contained all qualified studies, including those omitted by previous meta-analyses. Therefore, to our knowledge, the present meta-analysis includes all eligible data in assessing the effect of depression on risk of MI and coronary death.

The underlying mechanism of how depression contributes to CHD has not been fully elucidated. First, increasing evidence suggests that the association between depression and CHD prognosis may be explained by several biological mechanisms including inflammation, platelet reactivity, autonomic dysregulation, sleep architecture disruption, circadian rhythm disruption, anabolic/catabolic hormone imbalance, and others.36 A meta-analysis by Howren et al50 found that depression is associated with increased values of C-reactive protein, interleukin-1, and interleukin-6 and that these inflammatory factors were found to be linked to an increased risk of CHD and CHD mortality.51 Second, many poor health behaviors are associated with depression, such as smoking,52 increased alcohol consumption,53 and physical inactivity.54 These poor health behaviors are also well-established risk factors for CHD. Third, depression is correlated with obesity, diabetes mellitus, hypertension, and other major comorbid conditions, which themselves are also associated with increased risk of CHD. Controlling for these comorbid conditions in the current meta-analysis somewhat attenuated the association between depression and MI/coronary death, which indicates that comorbid conditions may confound the association between depression and CHD. Finally, use of antidepressants may contribute to the association we observed. Although the association was not attenuated by adjusting for antidepressant use, we still could not rule out this possibility because antidepressant use usually indicates more severe depression; however, information on type, duration, and dose of antidepressant medication use was not available in the original reports for further investigation.

This study has several limitations. First, a multivariate meta-regression analysis was not performed, because no significant difference was found between groups in the subgroup analyses. However, various subgroup analyses were conducted to investigate variations in the association among many subgroups of interest. Second, publication bias is suspected in this meta-analysis, as indicated by funnel plot and Egger test, but we adjusted for this using trim-and-fill method, after which the pooled HR remained significant (although the association was slightly attenuated). Furthermore, most original studies used self-report scales to measure depression, which may cause misclassification bias and lead to underestimation of the risk associated with MI and coronary death in this meta-analysis. Finally, some studies included in our meta-analysis lacked information on medication use. The role of medications in the association between depression and risk of MI and CHD death needs further investigation.

In conclusion, this meta-analysis of prospective cohort studies suggests that depression is significantly associated with an increased risk of MI and coronary death. Because of the high prevalence of depression and the incidence of MI and CHD mortality worldwide, the observed association between depression and MI and coronary death has important implications for public health. Prevention and treatment of depression may substantially decrease the risk of MI and coronary death globally. Further studies are warranted to investigate the underlying mechanisms for how depression causes increased risk of MI and CHD death.

Back to Top | Article Outline


We thank Nicole M. Pettenati for her consultation on the literature search strategy.

Back to Top | Article Outline


1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics, 2014 update: a report from the American Heart Association. Circulation 2014; 129:e28–e292.Epub 2013 Dec 18.
2. Townsend N, Wickramasinghe K, Ghatnagar P, et al.. Coronary heart disease statistics [Internet]. London: British Heart Foundation; 2012 [cited 2015 Aug 13]. Available from:∼/media/files/publications/research/2012_chd_statistics_compendium.pdf.
3. World Health Organization. Cardiovascular diseases (CVDs). Fact sheet no. 317 [Internet] [updated 2015 Jan; cited 2015 Aug 13]. Available from:
4. Shim RS, Baltrus P, Ye J, et al. Prevalence, treatment, and control of depressive symptoms in the United States: results from the National Health and Nutrition Examination Survey (NHANES), 2005–2008. J Am Board Fam Med 2011; 24:33–38.
5. Rugulies R. Depression as a predictor for coronary heart disease: a review and meta-analysis. Am J Prev Med 2002; 23:51–61.
6. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med 2003; 65:201–210.
7. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med 2004; 66:802–813.
8. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies. Eur Heart J 2006; 27:2763–2774.Epub 2006 Nov 2.
9. Van der Kooy K, van Hout H, Marwijk H, et al. Depression and the risk for cardiovascular diseases: systematic review and meta-analysis. Int J Geriatr Psychiatry 2007; 22:613–626.
10. Gan Y, Gong Y, Tong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014; 14:371.
11. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA 2000; 283:2008–2012.
12. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6:e1000097Epub 2009 Jul 21.
13. Davison GC, Neale JM. Abnormal Psychology. 6th ed.New York, NY: John Wiley & Sons; 1996.
14. Crea F, Lanza GA. Angina pectoris and normal coronary arteries: cardiac syndrome X. Heart 2004; 90:457–463.
15. Banks K, Lo M, Khera A. Angina in women without obstructive coronary artery disease. Curr Cardiol Rev 2010; 6:71–81.
16. Pratt LA, Ford DE, Crum RM, et al. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation 1996; 94:3123–3129.
17. Penninx BW, Guralnik JM, Mendes de Leon CF, et al. Cardiovascular events and mortality in newly and chronically depressed persons >70 years of age. Am J Cardiol 1998; 81:988–994.
18. Ford DE, Mead LA, Chang PP, et al. Depression is a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med 1998; 158:1422–1426.
19. Sesso HD, Kawachi I, Vokonas PS, et al. Depression and the risk of coronary heart disease in the Normative Aging Study. Am J Cardiol 1998; 82:851–856.
20. Whooley MA, Browner WS. Study of Osteoporotic Fractures Research Group. Association between depressive symptoms and mortality in older women. Arch Intern Med 1998; 158:2129–2135.
21. Mendes de Leon CF, Krumholz HM, Seeman TS, et al. Depression and risk of coronary heart disease in elderly men and women: New Haven EPESE, 1982–1991. Arch Intern Med 1998; 158:2341–2348.
22. Penninx BW, Beekman AT, Honig A, et al. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry 2001; 58:221–227.
23. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care 2005; 28:1339–1345.
24. Wulsin LR, Evans JC, Vasan RS, et al. Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study. Psychosom Med 2005; 67:697–702.
25. Ladwig KH, Marten-Mittag B, Lowel H, et al. Synergistic effects of depressed mood and obesity on long-term cardiovascular risks in 1510 obese men and women: results from the MONICA-KORA Augsburg Cohort Study 1984–1998. Int J Obes (Lond) 2006; 30:1408–1414.Epub 2006 Mar 21.
26. Ahto M, Isoaho R, Puolijoki H, et al. Stronger symptoms of depression predict high coronary heart disease mortality in older men and women. Int J Geriatr Psychiatry 2007; 22:757–763.
27. Surtees PG, Wainwright NW, Luben RN, et al. Depression and ischemic heart disease mortality: evidence from the EPIC-Norfolk United Kingdom prospective cohort study. Am J Psychiatry 2008; 165:515–523.Epub 2008 Feb 1.
28. Whang W, Kubzansky LD, Kawachi I, et al. Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses’ Health Study. J Am Coll Cardiol 2009; 53:950–958.
29. Janszky I, Ahnve S, Lundberg I, et al. Early-onset depression, anxiety, and risk of subsequent coronary heart disease: 37-year follow-up of 49,321 young Swedish men. J Am Coll Cardiol 2010; 56:31–37.
30. Brown JM, Stewart JC, Stump TE, et al. Risk of coronary heart disease events over 15 years among older adults with depressive symptoms. Am J Geriatr Psychiatry 2011; 19:721–729.
31. Sun WJ, Xu L, Chan WM, et al. Are depressive symptoms associated with cardiovascular mortality among older Chinese: a cohort study of 64,000 people in Hong Kong? Am J Geriatr Psychiatry 2013; 21:1107–1115.Epub 2013 Feb 6.
32. Capistrant BD, Gilsanz P, Moon JR, et al. Does the association between depressive symptoms and cardiovascular mortality risk vary by race? Evidence from the Health and Retirement Study. Ethn Dis 2013; 23:155–160.
33. Gustad LT, Laugsand LE, Janszky I, et al. Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study. Eur Heart J 2014; 35:1394–1403.Epub 2013 Sep 20.
34. Brunner EJ, Shipley MJ, Britton AR, et al. Depressive disorder, coronary heart disease, and stroke: dose-response and reverse causation effects in the Whitehall II cohort study. Eur J Prev Cardiol 2014; 21:340–346.Epub 2014 Feb 3.
35. Goldston K, Baillie AJ. Depression and coronary heart disease: a review of the epidemiological evidence, explanatory mechanisms and management approaches. Clin Psychol Rev 2008; 28:288–306.Epub 2007 May 25.
36. Lichtman JH, Bigger JT Jr, Blumenthal JA, et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008; 118:1768–1775.Epub 2008 Sep 29.
37. Wells GA, Shea B, O’Connell D, et al.. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta analyses [Internet]. Ottawa (ON), Canada: Ottawa Hospital Research Institute [cited 2015 Aug 13]. Available from:
38. Harris PA, Taylor R, Thielke R, et al. Research Electronic Data Capture (REDCap): a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42:377–381.
39. Walter SD, Cook RJ. A comparison of several point estimators of the odds ratio in a single 2 × 2 contingency table. Biometrics 1991; 47:795–811.
40. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21:1539–1558.
41. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327:557–560.
42. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315:629–634.
43. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56:455–463.
44. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics, 2015 update: a report from the American Heart Association. Circulation 2015; 131:e29–322.Epub 2014 Dec 17.
45. National Institutes of Health. US Department of Health and Human Services. Major depression among adults [Internet] [cited 2015 Aug 13] Available from:
46. Ferketich AK, Schwartzbaum JA, Frid DJ, et al. Depression as an antecedent to heart disease among women and men in the NHANES I study: National Health and Nutrition Examination Survey. Arch Intern Med 2000; 160:1261–1268.
47. Anda R, Williamson D, Jones D, et al. Depressed affect, hopelessness, and the risk of ischemic heart disease in a cohort of U.S. adults. Epidemiology 1993; 4:285–294.
48. Barefoot JC, Schroll M. Symptoms of depression, acute myocardial infarction, and total mortality in a community sample. Circulation 1996; 93:1976–1980.
49. Davidson KW, Schwartz JE, Kirkland SA, et al. Relation of inflammation to depression and incident coronary heart disease (from the Canadian Nova Scotia Health Survey [NSHS95] Prospective Population Study). Am J Cardiol 2009; 103:755–761.Epub 2009 Jan 24.
50. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71:171–186.Epub 2009 Feb 2.
51. Kaptoge S, Di Angelantonio E, Lowe G, et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010; 375:132–140.Epub 2009 Dec 22.
52. Anda RF, Williamson DF, Escobedo LG, et al. Depression and the dynamics of smoking: a national perspective. JAMA 1990; 264:1541–1545.
53. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend 1995; 39:197–206.
54. Camacho TC, Roberts RE, Lazarus NB, et al. Physical activity and depression: evidence from the Alameda County Study. Am J Epidemiol 1991; 134:220–231.

Supplemental Digital Content

Back to Top | Article Outline
Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.